Go to ACCD 2022 Website

Scientific Program ::

23-24 August 2014, Hotel Lalit, New Delhi.
DAY – 1, 23/08/2014
9.00 AM-10.00 AM REGISTRATION  
10.00 AM-10.15 AM Introduction and Welcome  
10.15 AM -11.30 AM Session 1- Pathophysiology of Type 2 Diabetes  
10.15 AM -10.30 AM Insulin Resistance - Muscle, Liver or Adipose Tissue? Adi Mehta
10.30 AM-10.45 AM CNS and Type 2 Diabetes - Is there a real link? Robert Zimmerman
10.45 AM -11.00 AM Deranged Islet Pathophysiology Adi Mehta
11.00 AM -11.15 AM Renal Contribution to Hyperglycemia Kevin Pantalone
11.15 AM -11.30 AM Discussion  
11.30 AM-12.00 PM TEA BREAK  
12.00 AM -1.15 PM Session 2 – Hyperglycemia Management  
12.00 AM -12.20 PM Hyperglycemia Management Guidelines – Practical Implications in  Indian Setting? V Mohan
12.20 AM -12.40 PM Metformin – Why preferred 1st line drug? Robert Zimmerman
12.40 AM -1.00 PM Sulfonylureas – do they really increase risk Kevin Pantalone
1.00 AM -1.15 PM Discussion  
1.15 PM -2.15 PM LUNCH BREAK  
1.45 AM -2.20 PM MEET THE PROFESSOR  
  Initiating Insulin in Type 2 Diabetes – is it always basal or we have other options. V Mohan, Kevin Pantalone
  Vit D and Type 2  Diabetes – Do we give it to all? Ambrish  Mithal, Adi Mehta
  Achieving Good Glycemic Control –  Role of SMBG, A1C and CGMS Robert Zimmerman, BM Makkar
2.30 AM - 3.45 PM Session 3 – Emerging Therapies  
2.30 AM -2.50 PM GLP1 Analogues – what’s new? Ambrish Mithal
2.50 AM -3.10 PM GLP1 Analogues and Insulin Combination Therapy Kevin Pantalone
3.10 AM -3.30 PM SGLT 2 Inhibitors – Is Glycosuria Good? Robert Zimmerman
3.30 AM-3.45 PM Discussion  
3.45 AM -4.15 PM TEA BREAK  
4.15 AM-6.00 PM Session 4 – Obesity Updated  
4.15 AM -4.35 PM Indian Obesity – The Asian Indian Phenotype Shashank Joshi
4.35 AM-4.55 PM Obesity – Is it healthy to be overweight? BMMakkar
4.55 AM -5.15 PM Gut Microbiota - Does Poop Hold the Answer? Adi Mehta
5.15 AM -5.35 PM New Pharmacologics for Obesity- Much Ado About So Little?   Kevin Pantalone
5.35 AM -6.00 PM Discussion  
6.00 AM - 7.20 PM Debate1- Managing Triglcerides is important in Indian diabetics – Debate Yes  Shashank Joshi No - Adi Mehta
  Debate2- To SFU or not to SFU, that is the question? Yes – BMMakkar No- Robert Zimmerman,
7.45 PM ONWARD BANQUET  
23-24 August 2014, Hotel Lalit, New Delhi.
Day 2- 24/08/2014
9.00 AM - 10.15 AM Session 1  
9.00 AM -  9.20 AM New Hypertension Guidelines - Are We Regressing? Adi Mehta
9.20 AM -  9.40 AM DPP4 Inhibitors –safety status/issues after SAVOR-TIMI & EXAMINE. Kevin Pantalone
9.40 AM - 10.00 AM New vs. Old Lipid Management Guidelines - Are They Really A Step Forward? Adi Mehta
10.00 AM -1 0.15 AM Discussion  
10.15 AM - 10.45 AM Update Lecture 1- Transitioning to Insulin Programs Adi Mehta
10.45 AM - 11.15 AM Update Lecture 2- Insulins of Future Robert Zimmerman
11.15 AM - 11.45 AM TEA BREAK  
11.45 AM - 1.00 PM Session 2  
11.45 AM - 12.05 PM Comeback of Glitazones – Where do they stand in today’s clinical practice Shashank Joshi
12.05 AM - 12.25 PM Cholesterol Management2015 – Role of Non-Statins Adi Mehta
12.25 AM - 12.45 PM Inpatient Hyperglycemia Management Ambrish Mithal
12.45 AM - 1.00 PM Discussion  
1.00 PM - 2.00 PM LUNCH BREAK  
1.30 PM - 2.20 PM MEET THE PROFESSOR  
  How Early Can One Identify Progression of Type 2 Diabetes V Mohan, Adi Mehta
  What should be the 2nd line therapy, after metformin, for the majority of DM-2 patients with inadequate glycemic control Ambrish Mithal, Kevin Pantalone
  TBD  
2.30 PM -  4.00 PM Session 3  
2.30 PM -  2.50 PM Has time come to take genomics to the diabetes centre? V Mohan
2.50 PM - 3.10 PM Hypoandrogenic hypogonadism in Type 2 Diabetes Kevin Pantalone
3.10 PM - 3.30 PM Practical Hypertension Therapy Choices Robert Zimmerman
3.30 PM - 3.50 PM Is Diabetes Preventable in 21st Century? Adi Mehta
3.50 PM - 4.10 PM Discussion  
4.10 PM  - 4.30 PM Wrap Up and Valedictory  
  TEA BREAK and CLOSE  

Important Dates

Enquiry

Name
Mobile
Email
Massage

Contact


Suite No. 510/511, DLF City Court
MG Road, Gurgaon 122 004 , Haryana, India
Pratibha Verma
Mob: +91 965 06 07 824
Tel: +91-124 46 17 718
Fax: +91-124 46 17 777